Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice
Authors:
- Melody NiMNMelody Ni
- Suzanne S. GisbertzSGSuzanne S. Gisbertz
- Mark I. van Berge HenegouwenMark I. van Berge Henegouwen
- On Behalf Of The Dutch Upper Gi Cancer AuditOAOn Behalf Of The Dutch Upper Gi Cancer Audit
- TIME Study GroupTGTIME Study Group
- 18 May 2020
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 38 (19) , 2130-2139
Abstract
PURPOSE: The aim of this study was to examine the external validity of the randomized TIME trial, when minimally invasive esophagectomy (MIE) was implemented nationally in the Netherlands, using data from the Dutch Upper GI Cancer Audit (DUCA) for transthoracic esophagectomy. METHODS: Original patient data from the TIME trial were extracted along with data from the DUCA dataset (2011-2017). Multivariate analysis, with adjustment for patient factors, tumor factors, and year of surgery, was performed for the effect of MIE versus open esophagectomy on clinical outcomes. RESULTS: One hundred fifteen patients from the TIME trial (59 MIE v 56 open) and 4,605 patients from the DUCA dataset (2,652 MIE v 1,953 open) were included. In the TIME trial, univariate analysis showed that MIE reduced pulmonary complications and length of hospital stay. On the contrary, in the DUCA dataset, MIE was associated with increased total and pulmonary complications and reoperations; however, benefits included increased proportion of R0 margin and lymph nodes harvested, and reduced 30-day mortality. Multivariate analysis from the TIME trial showed that MIE reduced pulmonary complications (odds ratio [OR], 0.19; 95% CI, 0.06 to 0.61). In the DUCA dataset, MIE was associated with increased total complications (OR, 1.36; 95% CI, 1.19 to 1.57), pulmonary complications (OR, 1.50; 95% CI, 1.29 to 1.74), reoperations (OR, 1.74; 95% CI, 1.42 to 2.14), and length of hospital stay. Multivariate analysis of the combined and MIE datasets showed that inclusion in the TIME trial was associated with a reduction in reoperations, Clavien-Dindo grade > 1 complications, and length of hospital stay. CONCLUSION: When adopted nationally outside the TIME trial, MIE was associated with an increase in total and pulmonary complications and reoperation rate. This may reflect nonexpert surgeons outside of high-volume centers performing this minimally invasive technique in a nonstandardized fashion outside of a controlled environment.Keywords
This publication has 29 references indexed in Scilit:
- IDEAL framework for surgical innovation 1: the idea and development stagesBMJ, 2013
- IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stagesBMJ, 2013
- IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stageBMJ, 2013
- Trends in Hospital Volume and Operative Mortality for High-Risk SurgeryNew England Journal of Medicine, 2011
- The National Training Programme for Laparoscopic Colorectal Surgery in England: a new training paradigmColorectal Disease, 2011
- Demonstration of the IDEAL recommendations for evaluating and reporting surgical innovation in minimally invasive oesophagectomyBritish Journal of Surgery, 2011
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancerBritish Journal of Cancer, 2008
- Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago–gastric junction and the stomachEuropean Journal of Cancer, 2007
- Hospital Volume and Surgical Mortality in the United StatesNew England Journal of Medicine, 2002